Index
By TNW
About Index
Trending news
Lists
Pricing
Sign up or sign in
Apothecary Capital
0
Apothecary Capital
Suggest edits
Overview
News
Investments
3
Portfolio
Portfolio Tracker
Add info
Xconomy
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits
Health
Science
$62,000,000
Post-IPO equity
biospace
FibroGen Gets 62 Million License Payment from Partner AstraZeneca PLC
Health
Science
